New strategies for the management of diverticular disease: insights for the clinician
- PMID: 23634185
- PMCID: PMC3625022
- DOI: 10.1177/1756283X13478679
New strategies for the management of diverticular disease: insights for the clinician
Abstract
Diverticulosis is one of the most common gastrointestinal conditions affecting the general population in the Western world. It is estimated that over 2.5 million people are affected by diverticular disease in the United States. The spectrum of clinical manifestations of diverticulosis ranges from asymptomatic diverticulosis to complicated diverticulitis. Treatment for symptomatic diverticular disease is largely based on symptoms. Traditional therapy includes fiber, bowel rest, antibiotics, pain control and surgery for selected cases. This review discusses recent advances in the medical treatment of diverticular disease such as the use of mesalamine, rifaximin and probiotics as our understanding of the disease evolves.
Keywords: diverticular disease; diverticulitis; diverticulosis.
Conflict of interest statement
References
-
- Aldoori W., Giovannucci E., Rimm E., Wing A., Trichopoulos D., Willett W., et al. (1994) A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr 60: 757–764 - PubMed
-
- Aldoori W., Giovannucci E., Rimm E., Wing A., Trichopoulos D., Willett W. (1995) A prospective study of alcohol, smoking, caffeine, and the risk of symptomatic diverticular disease in men. Ann Epidemiol 5: 221–228 - PubMed
-
- Arfwidsson S., Knocking N., Lehmann L., Winberg T. (1964) Pathogenesis of multiple diverticula of the sigmoid colon in diverticular disease. Acta Chir Scand 342(Suppl.): 1–68 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
